AT
Akari Therapeutics Plc
SEC filingOther Health Care · Tampa, FL
Amount raised$1.8Msold at filing
Total offering$5.5M$3.7M still open
Investors in the raise6count reported to the SEC
FiledJun 3, 2026first sale May 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ray PrudoDirector
Rob BazemoreDirector
Hoyoung HuhDirector
Samir PatelDirector
Sandip PatelDirector
Abizer GaslightwalaExecutive Officer, Director
Kameel FaragExecutive Officer
Jim NealDirector
Executive officers, directors and promoters as listed on the Form D.